Air Optix® Night and Day® Aqua Therapeutic Wear

Launched by ALCON RESEARCH · Jul 14, 2023

Keywords

ClinConnect Summary

In this retrospective, real world evidence study, the subjects wore Air Optix Night and Day Aqua (AONDA) soft contact lenses or PureVision 2 (PV2) soft contact lenses as a therapeutic lens for the treatment of a corneal condition with pain in one or both eyes as part of their eye care professional's treatment and management plan.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of a corneal condition with pain for which AONDA or PV2 contact lenses were placed on one or both eye(s) as a therapeutic contact lens at Baseline.
• • Baseline and Follow-up (up to 1 year from Baseline) charts available.
• • Other protocol-defined inclusion criteria may apply.
• Exclusion Criteria:
• • Had a condition (pathological, behavioral, and/or situational) that contraindicated therapeutic CL wear or confounds study results during the data collection period.
• • Used systemic or ocular medication that would confound study results during the data collection period.
• • Other protocol-defined exclusion criteria may apply.